Search
Patexia Research
Case number 1:20-cv-00791

Eisai Co., Ltd. et al v. MSN Pharmaceuticals Inc. > Documents

Date Field Doc. No.Description (Pages)
Oct 21, 2020 13 Patent/Trademark Report to Commissioner (5)
Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl)
Oct 15, 2020 12 Consent Judgment (4)
Docket Text: CONSENT JUDGMENT (see document for further details). Signed by Judge Leonard P. Stark on 10/15/20. (ntl)
Oct 13, 2020 11 Proposed Consent Judgment (4)
Docket Text: PROPOSED CONSENT JUDGMENT by Eisai Co., Ltd., Eisai Inc., Novartis Pharma AG. (Raucci, Anthony)
Sep 22, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to Move, Answer or otherwise Respond to Complaint to October 21, 2020 filed by MSN Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 9/22/20. (ntl)
Sep 21, 2020 9 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of MSN Pharmaceuticals Inc. (Myer, R.)
Sep 21, 2020 10 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to Move, Answer or otherwise Respond to Complaint to October 21, 2020 - filed by MSN Pharmaceuticals Inc.. (Myer, R.)
Aug 3, 2020 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Eisai Inc., Eisai Co., Ltd., Novartis Pharma AG: For MSN Pharmaceuticals Inc. waiver sent on 7/23/2020, answer due 9/21/2020. (Blumenfeld, Jack)
Jun 17, 2020 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Jun 11, 2020 7 Summons Issued - Electronic (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (myr)
Jun 10, 2020 1 Exhibit A (9)
Jun 10, 2020 1 Civil Cover Sheet (1)
Jun 10, 2020 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
Jun 10, 2020 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 18, 2020. Date of Expiration of Patent: November 14, 2022. ** Pediatric exclusivity - May 14, 2023. Thirty Month Stay Deadline: 11/18/2022. (myr)
Jun 10, 2020 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1. (myr)
Jun 10, 2020 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Co., Ltd. for Eisai Inc. filed by Eisai Co., Ltd., Eisai Inc. (myr)
Jun 10, 2020 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharma AG filed by Novartis Pharma AG. (myr)
Menu